DNA edit leads to apparent cure in infant; CDER director to step down; More biotechs emerge with assets from China; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints ...